Attached files
| file | filename |
|---|---|
| 10-K - CardioGenics Holdings Inc. | v173825_10k.htm |
| EX-31.1 - CardioGenics Holdings Inc. | v173825_ex31-1.htm |
| EX-31.2 - CardioGenics Holdings Inc. | v173825_ex31-2.htm |
| EX-23.2 - CardioGenics Holdings Inc. | v173825_ex23-2.htm |
| EX-21.1 - CardioGenics Holdings Inc. | v173825_ex21-1.htm |
| EX-23.1 - CardioGenics Holdings Inc. | v173825_ex23-1.htm |
| EX-10.29 - CardioGenics Holdings Inc. | v173825_ex10-29.htm |
| EX-10.28 - CardioGenics Holdings Inc. | v173825_ex10-28.htm |
| EX-10.30 - CardioGenics Holdings Inc. | v173825_ex10-30.htm |
| EX-10.31 - CardioGenics Holdings Inc. | v173825_ex10-31.htm |
EXHIBIT 32.1
Section
906 Certification by the Chief Executive Officer and Chief Financial
Officer
Each of
Yahia Gawad, Chief Executive Officer, and James Essex, Chief Financial Officer,
of CardioGenics Holdings Inc., a Nevada corporation (the “Company”) hereby
certifies pursuant to 18 U.S.C. ss. 1350, as added by ss. 906 of the
Sarbanes-Oxley Act of 2002, that, to their knowledge:
(1) The
Company’s annual report on Form 10-K for the period ended October 31, 2009
(“Form 10-K”) fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934, as amended; and
(2) The
information contained in the Form 10-K fairly presents, in all material
respects, the financial condition and results of operation of the
Company.
|
/s/
Yahia Gawad
|
/s/
James Essex
|
|
|
Name:
Yahia Gawad
|
Name:
James Essex
|
|
|
Title: Chief
Executive Officer
|
Title:
Chief Financial Officer
|
|
|
Date:
February 16, 2010
|